11 results
10-K
2023 FY
APGE
Apogee Therapeutics, Inc.
5 Mar 24
Annual report
6:15am
or treatment guidelines, we may not generate significant revenue from sales of such products, even if approved.
The dual class structure of our common stock … may limit your ability to influence corporate matters and may limit your visibility with respect to certain transactions.
The dual class structure
DRS
APGE
Apogee Therapeutics, Inc.
9 Feb 24
Draft registration statement
12:00am
by competition, physician choice or treatment guidelines, we may not generate significant revenue from sales of such products, even if approved.
The dual class structure … .
The dual class structure of our common stock may limit your ability to influence corporate matters. Holders of our common stock are entitled to one
10-Q
ssq8wt8x
28 Aug 23
Quarterly report
8:00am
424B4
wzh7kdboarm6u6
17 Jul 23
Prospectus supplement with pricing info
4:08pm
S-1
x8inx96zefe3gy
22 Jun 23
IPO registration
4:19pm
DRS/A
x8jlq5 8c08t
5 Jun 23
Draft registration statement (amended)
12:00am
DRS
g5ez51gfx4
28 Apr 23
Draft registration statement
12:00am
- Prev
- 1
- Next